Cargando…
Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis
Castration-resistant prostate cancer (PCa) is refractory to hormone therapy and new strategies for treatment are urgently needed. We found that androgen-insensitive (AI) PCa cells, LNCaP-AI, are reprogrammed to upregulate the mitotic kinase Plk1 and other M phase cell cycle proteins, which may under...
Autores principales: | Deeraksa, Arpaporn, Pan, Jing, Sha, Youbao, Liu, Xian-De, Eissa, N Tony, Lin, Sue-Hwa, Yu-Lee, Li-yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499666/ https://www.ncbi.nlm.nih.gov/pubmed/22890325 http://dx.doi.org/10.1038/onc.2012.309 |
Ejemplares similares
-
Integrin Involvement in Freeze Resistance of Androgen-Insensitive Prostate Cancer
por: Baust, John G., et al.
Publicado: (2010) -
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
por: Li, Tzu-Huey, et al.
Publicado: (2007) -
Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis
por: Weiderhold, Kimberly N., et al.
Publicado: (2016) -
The challenges of androgen insensitivity syndrome
por: Ovidiu, Bratu, et al.
Publicado: (2021) -
Embryonal carcinoma in androgen insensitivity syndrome
por: Barmon, Debabrata, et al.
Publicado: (2011)